BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2849995)

  • 21. Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553.
    Killeen KP; Collier RJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):162-6. PubMed ID: 1347236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
    Prentice GA; Merrill AR
    Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of eliminating a disulfide bridge within domain II of Pseudomonas aeruginosa exotoxin A.
    Madshus IH; Collier RJ
    Infect Immun; 1989 Jul; 57(7):1873-8. PubMed ID: 2499539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active-site mutations of diphtheria toxin: role of tyrosine-65 in NAD binding and ADP-ribosylation.
    Blanke SR; Huang K; Collier RJ
    Biochemistry; 1994 Dec; 33(51):15494-500. PubMed ID: 7803411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic activity of a recombinant chimaeric protein between Pseudomonas aeruginosa exotoxin A and Corynebacterium diphtheriae diphtheria toxin.
    Guidi-Rontani C
    Mol Microbiol; 1992 May; 6(10):1281-7. PubMed ID: 1640830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dipeptide insertion in domain I of exotoxin A that impairs receptor binding.
    Chaudry GJ; Wilson RB; Draper RK; Clowes RC
    J Biol Chem; 1989 Sep; 264(25):15151-6. PubMed ID: 2570071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
    Arora N; Klimpel KR; Singh Y; Leppla SH
    J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
    Jørgensen R; Wang Y; Visschedyk D; Merrill AR
    EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Anal Biochem; 2001 May; 292(1):26-33. PubMed ID: 11319814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.
    Lukac M; Pier GB; Collier RJ
    Infect Immun; 1988 Dec; 56(12):3095-8. PubMed ID: 2460407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the enzymatic component of Clostridium perfringens iota-toxin.
    Nagahama M; Sakaguchi Y; Kobayashi K; Ochi S; Sakurai J
    J Bacteriol; 2000 Apr; 182(8):2096-103. PubMed ID: 10735850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A.
    Zhang Y; Liu S; Lajoie G; Merrill AR
    Biochem J; 2008 Jul; 413(1):163-74. PubMed ID: 18373493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the structure-function relationship of Pseudomonas aeruginosa exotoxin A.
    Wick MJ; Hamood AN; Iglewski BH
    Mol Microbiol; 1990 Apr; 4(4):527-35. PubMed ID: 2112672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A.
    Chow JT; Chen MS; Wu HC; Hwang J
    J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas exotoxin: chimeric toxins.
    Pastan I; FitzGerald D
    J Biol Chem; 1989 Sep; 264(26):15157-60. PubMed ID: 2504717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.